Is a complete LON/0R02 research report available?

No complete published report is available for lon/0R02 (LON/0R02) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

LON/0R02 (LON/0R02)

London Stock Exchange: LON/0R02 · USD

$0.26

+0.01 (+2.1%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-30 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first LON/0R02 analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	907.1K
Revenue (ttm)	99.2K
Net income (ttm)	-10.5M
EPS (ttm)	-$4.05
Volume	6,100
Beta	1.13

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 99.2K
Net income (ttm): -10.5M
EPS (ttm): -$4.05
Market cap: 907.1K

All LON/0R02 indicators

Market & fundamental data

Available fields

168

Groups with data

Currency

USD

Showing 168 of 168 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	12
Employees Change	2%
Employees Change Percent	15.38
Enterprise value	$-2.4M
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biotechnology
Isin	US68620A3023
Last refreshed	2026-07-30
Market cap	$907,119
Price	$0.26
Price currency	USD
Rev Per Employee	8,267.25x
Sector	Healthcare
Sector PE	22.69
Sector PE Fwd	14.69
Sic	2836
Symbol	lon/0R02
Website	https://vivosim.ai

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-1,155.68%
FCF yield	-892.84%
P/B ratio	-1.09x
P/S ratio	9.14x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-3.1M
Net Income	$-10.5M
Net Income Growth Quarters	8%
Net Income Growth Years	2%
Pretax Margin	-10,565.64%
Profit Per Employee	$-873,614
ROA	-65.16
Roa5y	-54.39
ROCE	-249.7
ROE	-294.8
Roe5y	-118.8
ROIC	-130.2

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-97.91%
Cagr3y	-82.01%
Cagr5y	-74.49%
EPS Growth Quarters	2
EPS Growth Years	0
Revenue Growth	-9.03x
Revenue Growth Q	-21.57x
Revenue Growth Quarters	1x
Revenue Growth Years	1x
Revenue Growth3 Y	-29.26x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.01
Assets	$5.6M
Cash	$3.8M
Current Assets	$5M
Current Liabilities	$2.1M
Debt	$427,877
Debt FCF	$-0.05
Equity	$-832,278
Interest Coverage	-957.2
Liabilities	$6.4M
Long Term Assets	$636,161
Long Term Liabilities	$4.3M
Net Cash	$3.4M
Net Cash By Market Cap	$372
Net Cash Growth	-56.46%
Tangible Book Value	$-832,278
Tangible Book Value Per Share	$-0.29
WACC	7.66

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.38
Net Working Capital	$-467,257
Quick ratio	2.18
Working Capital	$2.9M
Working Capital Turnover	$0.02

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-76.85%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-97.9%
200-day SMA	10.99
3Y total return	-99.42%
50-day SMA	5.35
50-day SMA vs 200-day SMA	50under200
5Y total return	-99.89%
All Time High	422.4
All Time High Change	-99.94%
All Time High Date	2018-05-22
All Time Low	0.26
All Time Low Change	1.34%
All Time Low Date	2025-03-20
ATR	1.26
Beta	1.13
Ch YTD	-94.87
High	0.28
High52	22.2
High52 Date	2025-02-26
High52ch	-98.81%
Low	0.26
Low52	0.26
Low52 Date	2025-03-20
Low52ch	1.34%
Ma50ch	-95.05%
Price vs 200-day SMA	-97.59%
RSI	38.65
RSI Monthly	30.53
RSI Weekly	35.28
Sharpe ratio	0.07x
Sortino ratio	0.2
Total Return	-76.85%
Tr YTD	-94.87
Tr1m	-94.04%
Tr1w	-94.74%
Tr3m	-93.66%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-8.7M
Operating margin	-8,768.7

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3,180,765%
Net Borrowing	-271,540.3
Shares Insiders	8.97%
Shares Institutions	2.81%
Shares Qo Q	1.09%
Shares Yo Y	76.85%
Short Ratio	0.01

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-8.3M
Adjusted OCF	-8,325,740.9
Average Volume	9,214.35x
Bv Per Share	-0.29
Ch1m	-94.04
Ch1w	-94.74
Ch1y	-97.9
Ch3m	-93.66
Ch3y	-99.42
Ch5y	-99.89
Ch6m	-95.66
Change	2.08%
Change From Open	-0.23
Close	0.26
Days Gap	2.32
Depreciation Amortization	160,829.7
Dollar Volume	1,613.5
Earnings Date	2026-08-10
EBIT	$-8.7M
EBITDA	$-8.5M
EPS	$-4.05
F Score	2
FCF	$-8.1M
FCF EV Yield	330.67x
Financing CF	3,366,221
Fiscal Year End	March
Founded	2,007
Income Tax	$1,515
Investing CF	71,187
Is Primary Listing	0
Last Earnings Date	2026-02-06
Last Report Date	2026-03-31
Last Split Date	2020-08-19
Last Split Type	Reverse
Ma150	8.46
Ma150ch	-96.87%
Ma20	6.32
Ma20ch	-95.81%
Net CF	-4,761,934
Next Earnings Date	2026-08-10
Open	0.27
Position In Range	18.42
Ppne	458,551.6
Price Date	2025-03-20
Relative Volume	0.66x
Revenue	99,207x
SBC By Revenue	231.3x
Share Based Comp	229,463
Tax By Revenue	1.53x
Tr6m	-95.66%
Volume	6,100
Z Score	-71.6

LON/0R02 (LON/0R02)

Coverage state: Market snapshot only — no published research

Generate the first LON/0R02 analysis

Price

Financial snapshot

Fair-value bridge

Latest news · LON/0R02

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LON/0R02 indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on LON/0R02

Frequently asked questions